These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29503208)

  • 1. Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery.
    Simm J; Klambauer G; Arany A; Steijaert M; Wegner JK; Gustin E; Chupakhin V; Chong YT; Vialard J; Buijnsters P; Velter I; Vapirev A; Singh S; Carpenter AE; Wuyts R; Hochreiter S; Moreau Y; Ceulemans H
    Cell Chem Biol; 2018 May; 25(5):611-618.e3. PubMed ID: 29503208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
    Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
    PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-based profiling for drug discovery: due for a machine-learning upgrade?
    Chandrasekaran SN; Ceulemans H; Boyd JD; Carpenter AE
    Nat Rev Drug Discov; 2021 Feb; 20(2):145-159. PubMed ID: 33353986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Throughput and Computational Repurposing for Neglected Diseases.
    Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
    Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How good are publicly available web services that predict bioactivity profiles for drug repurposing?
    Murtazalieva KA; Druzhilovskiy DS; Goel RK; Sastry GN; Poroikov VV
    SAR QSAR Environ Res; 2017 Oct; 28(10):843-862. PubMed ID: 29183230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of computational drug repurposing approaches: proposing a novel tensor-matrix-tensor factorization method.
    Zabihian A; Asghari J; Hooshmand M; Gharaghani S
    Mol Divers; 2024 Aug; 28(4):2177-2196. PubMed ID: 38683487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
    Iwata H; Sawada R; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Bioactivity Profile-Based Fingerprints for Building Machine Learning Models.
    Sturm N; Sun J; Vandriessche Y; Mayr A; Klambauer G; Carlsson L; Engkvist O; Chen H
    J Chem Inf Model; 2019 Mar; 59(3):962-972. PubMed ID: 30408959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
    Krausz E; de Hoogt R; Gustin E; Cornelissen F; Grand-Perret T; Janssen L; Vloemans N; Wuyts D; Frans S; Axel A; Peeters PJ; Hall B; Cik M
    J Biomol Screen; 2013 Jan; 18(1):54-66. PubMed ID: 22923784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
    Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
    J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision multidimensional assay for high-throughput microRNA drug discovery.
    Haefliger B; Prochazka L; Angelici B; Benenson Y
    Nat Commun; 2016 Feb; 7():10709. PubMed ID: 26880188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology.
    Kadurin A; Aliper A; Kazennov A; Mamoshina P; Vanhaelen Q; Khrabrov K; Zhavoronkov A
    Oncotarget; 2017 Feb; 8(7):10883-10890. PubMed ID: 28029644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Web-based drug repurposing tools: a survey.
    Sam E; Athri P
    Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale tracking and classification for automatic analysis of cell migration and proliferation, and experimental optimization of high-throughput screens of neuroblastoma cells.
    Harder N; Batra R; Diessl N; Gogolin S; Eils R; Westermann F; König R; Rohr K
    Cytometry A; 2015 Jun; 87(6):524-40. PubMed ID: 25630981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual plates: Getting the best out of high content screens.
    Shapira Lots I; Alroy I
    SLAS Discov; 2024 Jan; 29(1):77-85. PubMed ID: 38036292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTML Combinatorial Model of ChEMBL Compounds Assays for Multiple Types of Cancer.
    Bediaga H; Arrasate S; González-Díaz H
    ACS Comb Sci; 2018 Nov; 20(11):621-632. PubMed ID: 30240186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCS Methodology for Helping in Lab Scale Image-Based Assays.
    Soriano J; Mata G; Megias D
    Methods Mol Biol; 2019; 2040():331-356. PubMed ID: 31432486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.